PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 18, 2026European Addiction Research0 citationsOpen Access

Confidence in Managing Use and Minimising Harm as Mediators of Quality of Life among Anabolic-Androgenic Steroid Consumers in Alcohol and Other Drug Treatment Settings

View Full Paper
BBBenjamin BonentiNKNicholas Leigh KerswellGSGrace Shuttleworth

Key Points

  • This research examines how confidence in managing substance use and harm minimisation affects quality of life among anabolic-androgenic steroid (AAS) consumers in treatment.
  • Analyzed intake data from 517 adults reporting lifetime AAS use.
  • Employed mediation analyses to explore relationships between clinical risk, substance use management, and quality of life.
  • Quality of life was assessed through three domains: physical, psychological, and overall wellbeing.
  • Higher clinical steroid risk scores correlate with poorer quality of life across all domains.
  • Confidence in managing substance use significantly mediates the relationship between clinical risk and quality of life.
  • Improved confidence in harm minimisation is linked to better psychological wellbeing.

Abstract

Background: Anabolic-androgenic steroid (AAS) consumers frequently experience elevated physical and psychological risks, yet the psychological mechanisms linking risk exposure to health outcomes remain poorly understood. This study examined whether general confidence in managing substance use and minimising harm mediates the relationship between clinical risk and quality of life among AAS consumers engaged with community-based alcohol and other drug (AOD) services. Methods: Intake data from 517 adults (93.4% male) reporting lifetime AAS use were analysed, drawn from a broader cohort of 18,786 clients at Lives Lived Well services between 2020 and 2024. Mediation analyses tested whether two confidence variables, 1. substance use management and 2. harm minimisation, explained associations between clinical risk (defined by World Health Organisation – Alcohol, Smoking and Substance Involvement Screening Test steroid risk score), and three quality of life domains: physical, psychological, and overall wellbeing. Results: Higher clinical steroid risk scores were significantly associated with poorer quality of life across domains; however, these effects were fully mediated by lower general confidence in managing substance use and minimising harm among clients who reported AAS use. Confidence in consumption practices buffered against physical undesired effects, while confidence in harm reduction was strongly linked to psychological wellbeing. Conclusions: Among AAS consumers in AOD treatment, broader substance-use confidence appears meaningfully related to quality of life. While the confidence measures are general rather than AAS-specific, these findings provide a preliminary insight into confidence-related processes in a clinically underexamined group. Interventions that promote these strategies may offer a critical mechanism for ensuring this cohorts physical and psychological wellbeing.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Bonenti et al. (2026) studied this question.

synapsesocial.com/papers/696c79cde45ebfc9113cd415https://doi.org/10.1159/000550427
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Sociostructural correlates of clinical risk among Australian anabolic-androgenic steroid consumers2026
  2. 2Contemporary Health Monitoring and Promoting Behaviors Among Consumers of Anabolic-Androgenic Steroids2026
  3. 3Behavioural Intentions Associated with Exposure to Anabolic-Androgenic Steroid Testing Results: A Two-Phase, Multi-Wave Intervention Trial2026
  4. 4Differences in Mental Health, Risk Behaviors, and Social Determinants Among Anabolic-Androgenic Steroid Consumers With and Without Co-occurring Methamphetamine Use in Australia2026
  5. 5Creating Safer Injecting Practices Through Community‐Led Harm Reduction: Lessons From People Who Use Steroids for the Alcohol and Other Drug Sector2025